Advanced in Bronchiectasis

Dr. Luis I. De La Cruz

Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine
Upstate Lung And Critical Care Specialists PC
151 Harold Fleming Ct, 
Spartanburg, SC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Advanced in Bronchiectasis
Upstate Lung And Critical Care Specialists PC
151 Harold Fleming Ct, 
Spartanburg, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Luis De La Cruz is a Sleep Medicine specialist and a Pulmonary Medicine provider in Spartanburg, South Carolina. Dr. De La Cruz is rated as an Advanced provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pleurisy, and Advanced Bronchoscopy. Dr. De La Cruz is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Sleep Medicine
Pulmonary Medicine
Intensive Care Medicine
Licenses
Sleep Medicine in SC
Hospital Affiliations
Spartanburg Medical Center
Cherokee Medical Center
Union Medical Center
Languages Spoken
English
Castilian
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UPSTATE LUNG AND CRITICAL CARE SPECIALISTS PC
151 Harold Fleming Ct, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Recruiting
Publish Date: June 25, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Phase 2B, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversing Ticagrelor in Subjects Aged 50 to 80 Years Old
A Phase 2B, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversing Ticagrelor in Subjects Aged 50 to 80 Years Old
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 4 Less Clinical Trials

4 Total Publications

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Journal: Science (New York, N.Y.)
Published: November 23, 2021
Similar Doctors
Distinguished in Bronchiectasis
Dr. Joseph A. Boscia
Pulmonary Medicine
Distinguished in Bronchiectasis
Dr. Joseph A. Boscia
Pulmonary Medicine

Upstate Lung And Critical Care Specialists PC

151 Harold Fleming Ct, 
Spartanburg, SC 
 (0.1 miles away)
864-573-6320
Languages Spoken:
English, Castilian, Spanish
See accepted insurances
Accepting New Patients

Joseph Boscia is a Pulmonary Medicine provider in Spartanburg, South Carolina. Dr. Boscia is rated as a Distinguished provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, Asbestosis, and Advanced Bronchoscopy. Dr. Boscia is currently accepting new patients.

Distinguished in Bronchiectasis
Dr. Nadeem M. Inayet
Intensive Care Medicine | Pulmonary Medicine
Distinguished in Bronchiectasis
Dr. Nadeem M. Inayet
Intensive Care Medicine | Pulmonary Medicine

Fletcher Hospital Inc

50 Hospital Dr, 1c, 
Hendersonville, NC 
 (41.3 miles away)
828-687-9758
Languages Spoken:
English, Filipino
See accepted insurances
Accepting New Patients
Offers Telehealth

Nadeem Inayet is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Hendersonville, North Carolina. Dr. Inayet is rated as a Distinguished provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Lung Metastases, Pneumonia, Emphysema, Bullae, and Gastrostomy. Dr. Inayet is currently accepting new patients.

Distinguished in Bronchiectasis
Dr. Mark A. Hellreich
Pulmonary Medicine
Distinguished in Bronchiectasis
Dr. Mark A. Hellreich
Pulmonary Medicine
30 Choctaw St, 
Asheville, NC 
 (53.4 miles away)
828-255-7733
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Hellreich is a Pulmonary Medicine provider in Asheville, North Carolina. Dr. Hellreich is rated as a Distinguished provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Lung Metastases, Bronchiectasis, Pleural Effusion, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Hellreich is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. De La Cruz's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile